Alexander Rosenstein has sold CSII and made no open-market buys since Aug 2017
GC, Corp. Sec. at Cardiovascular Systems Inc
SEC CIK 0001680771 · Filings on SEC.gov ↗
Every filing
6 filings since Aug 2017, newest first
Cardiovascular Systems Inc
GC, Corp. Sec.
Cardiovascular Systems Inc
GC, Corp. Sec.
Cardiovascular Systems Inc
GC, Corp. Sec.
Cardiovascular Systems Inc
GC, Corp. Sec.
Cardiovascular Systems Inc
GC, Corp. Secy
Cardiovascular Systems Inc
GC, Corp. Secy
About Alexander Rosenstein
Alexander Rosenstein is the General Counsel and Corporate Secretary of Cardiovascular Systems, Inc., a medical device company focused on orbital atherectomy systems for the treatment of vascular and coronary disease.( He joined Cardiovascular Systems in September 2014 as Corporate Legal and Compliance Counsel and subsequently became General Counsel and Corporate Secretary, a role in which he oversees the company’s legal affairs, compliance functions, and corporate governance.( As a corporate insider, he has reported multiple equity transactions in Cardiovascular Systems, Inc. (CSII) under SEC Form 4 filings, reflecting his share ownership and ongoing participation in the company’s insider trading disclosures.(
Before serving in-house at Cardiovascular Systems, Rosenstein worked as an attorney at Fredrikson & Byron, P.A. in Minneapolis, where he was listed as counsel in securities filings for Cardiovascular Systems, Inc., demonstrating his background in corporate and securities law.( He holds a Juris Doctor (J.D.) degree, as reflected in corporate profiles that identify him as “Alexander Rosenstein, J.D.,” aligning with his responsibilities as General Counsel and Corporate Secretary.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.